Drugs widely prescribed to the elderly could be responsible for a decline in cognitive and physical function, according to research from the University of East Anglia and the Regenstrief Institute.
Much of the liver’s metabolic function is governed by circadian rhythms and UC Irvine researchers have now found two independent mechanisms by which this occurs.
At ResMed Inc, revenue for the fourth quarter was $415.2 million, flat compared to the quarter ended June 30, 2013. Net income was $87.7 million, an increase of 20% compared to the quarter ended June 30, 2013.
Liberty Voice reports on how dreamless sleep, or non-rapid eye movement (NREM), can be beneficial to the human body.
If your patients have a hard time getting up in the morning and usually hit the snooze button, this article from The Huffington Post might help them understand why that’s not the greatest for their health.
Sleeping pods are branching out from workplaces and universities; one inventor has come up with a way to create stackable pods to utilize at places like music festivals and possibly for post-disaster housing, Fast Company reports.
Alexza Pharmaceuticals Inc has identified two new Staccato-based product candidates for development: AZ-008 and AZ-009, which will incorporate the active pharmaceutical ingredient ropinirole, a dopamine agonist, into Alexza’s proprietary Staccato system.
If your patients are asking about alternative remedies for insomnia, you may want to look into the studies compiled in this article by ABC Health & Wellbeing.
Through the lens of a sleep disorder patient, Peoria Public Radio discusses pediatric sleep.
Have you been following the development of Sense, the Kickstarter-funded sleep tracker? It continues to make headlines as it crosses the $1 million funding threshold, reports the BBC.